Advisory Services Network’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
DTC
MAM
TCM
SCM
Advisory Services Network's NKTR Position: Q1 2024 in Review
Advisory Services Network held its Nektar Therapeutics (NKTR) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2871.
Advisory Services Network first reported a position in NKTR in Q1 2015 and has held it in 16 quarters since. The position peaked at $65K in Q1 2020. 124 funds tracked by Wall St. Rank hold NKTR as of Q1 2024.
- Advisory Services Network held 0 shares of Nektar Therapeutics worth $0 as of Q1 2024.
- Advisory Services Network left its Nektar Therapeutics share count unchanged in Q1 2024.
- Nektar Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2024, its #2871 holding.
- Advisory Services Network first reported a position in Nektar Therapeutics in Q1 2015 and has held it in 16 quarters since.
- Advisory Services Network's Nektar Therapeutics position peaked at $65K in Q1 2020.
- 124 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2024.
Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.